Position in TBPH
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$240,739
-$36,786 QoQ
Shares Held
14,833
0.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JAMES INVESTMENT RESEARCH, INC. holds $5,613,887 across 7 Biotechnology names. TBPH ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INVA |
Innoviva, Inc.
|
77,227 | $1,799,389 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
26,327 | $1,701,514 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
33,685 | $834,040 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
17,122 | $690,187 | |
| 5 | ZYME |
Zymeworks Inc.
|
10,925 | $273,562 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
This page
|
14,833 | $240,739 | |
| 7 | IRD |
Opus Genetics, Inc.
|
16,364 | $74,456 |
All Filings in TBPH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240,739 | 14,833 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $277,525 | 14,833 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||